CEBPB and inflammatory bowel disease: Subsequently, we detected the mRNA levels of CEBPB, PCK1, and EFNA1 in LPS-stimulated Caco-2 cells after being treated with the marketed drugs commonly used for the treatment of IBD (sulfasalazine, mesalazine, olsalazine, and tofacitinib).